Drug details

Omlonti (omidenepag isopropyl ophthalmic solution)

type of Antiglaucoma, Prostaglandin Agonists

Omlonti (omidenepag isopropyl ophthalmic solution) 0.002% is a relatively selective prostaglandin E2 (EP2) receptor agonist, indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• itching,
• chest pain,
• blurred vision,
• coughing,
• wheezing,
• pain,
• feeling like something is in your eye
• increased sensitivity to light,
• dry eye,
• swelling in the arms or legs,
• visual impairment,
• pain in the eye,
• excess tearing,
• white discharge from the eye,
• swollen eye lids,
• intense itching of the eye, and

The following drugs are related to Omlonti, either as a replacement or used together:

• Lumigan (bimatoprost ophthalmic solution 0.03% for glaucoma)
• Cosopt (dorzolamide hydrochloride-timolol maleate ophthalmic solution)
• Xalatan (latanoprost ophthalmic)
• Vyzulta (latanoprostene bunod ophthalmic solution)
• Rhopressa (netarsudil ophthalmic)
• Zioptan (tafluprost)
• Travatan (travoprost)
• Travatan Z (travoprost ophthalmic solution)